As of 2026-04-18, the Intrinsic Value of 89Bio Inc (ETNB) is -15.16 USD. This 89Bio valuation is based on the model Peter Lynch Fair Value. With the current market price of 14.84 USD, the upside of 89Bio Inc is -202.15%.
Based on its market price of 14.84 USD and our intrinsic valuation, 89Bio Inc (ETNB) is overvalued by 202.15%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -15.16 - -15.16 | -15.16 | -202.15% |
| P/E | (56.39) - (65.43) | (61.55) | -514.7% |
| DDM - Stable | (24.32) - (97.84) | (61.08) | -511.6% |
| DDM - Multi | (0.56) - (1.74) | (0.85) | -105.7% |
| Market Cap (mil) | 2,203.59 |
| Beta | 1.71 |
| Outstanding shares (mil) | 148.49 |
| Enterprise Value (mil) | 2,110.67 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.76% |
| Cost of Debt | 5.00% |
| WACC | 9.68% |